Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Galassi

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2019
Nutritional vitamin D in CKD: Should we measure? Should we treat?Irene Capelli, Giuseppe Cianciolo, Lorenzo Gasperoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 2006
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium bindersAndrea Galassi, David M Spiegel, Antonio Bellasi, et al.
Expert Review of Clinical Pharmacology|August 29, 2017
Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney diseaseAndrea Galassi, Antonio Bellasi, Paola Ciceri, et al.
Nutrients|January 17, 2019
Vitamin K in Chronic Kidney DiseaseMario Cozzolino, Michela Mangano, Andrea Galassi, et al.
Contributions to Nephrology|May 3, 2008
Preventive measures and new pharmacological approaches of calcium and phosphate disordersMario Cozzolino, Andrea Galassi, Sabina Pasho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 18, 2009
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patientsMario Cozzolino, Maria Luisa Biondi, Andrea Galassi, et al.
Therapeutics and Clinical Risk Management|June 16, 2017
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetideMario Cozzolino, Andrea Galassi, Ferruccio Conte, et al.
The Medico-Legal Journal|August 16, 2019
Sudden death and Takayasu's arteritis: The role of histopathological investigationIsabella Aquila, Pietrantonio Ricci, Andrea Galassi, et al.
Journal of Forensic Sciences|September 4, 2015
Reliability of Craniofacial Superimposition Using Three-Dimension Skull ModelDaniel Gaudio, Lara Olivieri, Danilo De Angelis, et al.
Clinical Kidney Journal|June 8, 2021
Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithmAndrea Galassi, Gianmarco Podda, Paola Monciino, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2019
Nutritional vitamin D in CKD: Should we measure? Should we treat?Irene Capelli, Giuseppe Cianciolo, Lorenzo Gasperoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 1, 2006
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium bindersAndrea Galassi, David M Spiegel, Antonio Bellasi, et al.
Expert Review of Clinical Pharmacology|August 29, 2017
Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney diseaseAndrea Galassi, Antonio Bellasi, Paola Ciceri, et al.
Nutrients|January 17, 2019
Vitamin K in Chronic Kidney DiseaseMario Cozzolino, Michela Mangano, Andrea Galassi, et al.
Contributions to Nephrology|May 3, 2008
Preventive measures and new pharmacological approaches of calcium and phosphate disordersMario Cozzolino, Andrea Galassi, Sabina Pasho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 18, 2009
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patientsMario Cozzolino, Maria Luisa Biondi, Andrea Galassi, et al.
Therapeutics and Clinical Risk Management|June 16, 2017
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetideMario Cozzolino, Andrea Galassi, Ferruccio Conte, et al.
The Medico-Legal Journal|August 16, 2019
Sudden death and Takayasu's arteritis: The role of histopathological investigationIsabella Aquila, Pietrantonio Ricci, Andrea Galassi, et al.
Journal of Forensic Sciences|September 4, 2015
Reliability of Craniofacial Superimposition Using Three-Dimension Skull ModelDaniel Gaudio, Lara Olivieri, Danilo De Angelis, et al.
Clinical Kidney Journal|June 8, 2021
Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithmAndrea Galassi, Gianmarco Podda, Paola Monciino, et al.
Pageof 11